EMILY AVERILL: Open Payments
NPI 1497270771 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 33 payments from 8 companies in 2025. Trend: 2023 $180 · 2024 $347 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $153 |
| Sumitomo Pharma America, Inc. | 8 | $134 |
| Biogen, Inc. | 5 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Exeltis, USA Inc. | 4 | $80 |
| Organon LLC | 2 | $43 |
| SHIELD THERAPEUTICS INC | 2 | $42 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $11 |
Products named: Veozah, MYFEMBREE, ZURZUVAE, SLYND, Mirena, NEXPLANON, ACCRUFER, Kyleena.
Industry payments across AR — which companies pay providers there.
